Key facts
- This page summarizes ARCH Venture Partners IX, LLC's Form 4 filing for Vir Biotechnology, Inc. (VIR).
- 10 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 07 Sep 2022, 20:29.
ARCH Venture Partners IX, LLC - 02 Sep 2022 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- VIR
- Reported as of
- 02 Sep 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 07 Sep 2022, 20:29:00 UTC
- Prior SEC filing
- 01 Sep 2022
- Next SEC filing
- 29 Jul 2025
- Source filing
- View source filing
- Reporting owner signature
- By: ARCH Venture Partners IX, LLC, By: /s/ Mark McDonnell, as Attorney-in-Fact for Keith Crandell, Managing Director
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
ARCH Venture Partners IX, LLC filed Form 4 for Vir Biotechnology, Inc. (VIR) on 07 Sep 2022.
Change
- Previous filing in this sequence was filed on 01 Sep 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VIR
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- -196,003
- Change %
- -3.2%
- Price
- $0.000000
- Shares after
- 5,865,567
- Date
- 02 Sep 2022
- Ownership
- See footnote
- Footnotes
- F1, F2
VIR
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- -253,997
- Change %
- -3.2%
- Price
- $0.000000
- Shares after
- 7,601,096
- Date
- 02 Sep 2022
- Ownership
- See footnote
- Footnotes
- F1, F3
VIR
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- +11,763
- Change %
- +4.8%
- Price
- $0.000000
- Shares after
- 258,581
- Date
- 02 Sep 2022
- Ownership
- Direct
- Footnotes
- F1, F4, F5
VIR
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- +1,338
- Change %
- +4.8%
- Price
- $0.000000
- Shares after
- 28,946
- Date
- 02 Sep 2022
- Ownership
- Direct
- Footnotes
- F1, F4, F6
VIR
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- +2,662
- Change %
- +4.8%
- Price
- $0.000000
- Shares after
- 57,912
- Date
- 02 Sep 2022
- Ownership
- See footnote
- Footnotes
- F1, F4, F7
VIR
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- -239,559
- Change %
- -4.1%
- Price
- $0.000000
- Shares after
- 5,626,008
- Date
- 06 Sep 2022
- Ownership
- See footnote
- Footnotes
- F1, F2
VIR
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- -310,441
- Change %
- -4.1%
- Price
- $0.000000
- Shares after
- 7,290,655
- Date
- 06 Sep 2022
- Ownership
- See footnote
- Footnotes
- F1, F3
VIR
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- +14,383
- Change %
- +5.6%
- Price
- $0.000000
- Shares after
- 272,964
- Date
- 06 Sep 2022
- Ownership
- Direct
- Footnotes
- F1, F4, F5
VIR
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- +1,624
- Change %
- +5.6%
- Price
- $0.000000
- Shares after
- 30,570
- Date
- 06 Sep 2022
- Ownership
- Direct
- Footnotes
- F1, F4, F6
VIR
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- +3,248
- Change %
- +5.6%
- Price
- $0.000000
- Shares after
- 61,160
- Date
- 06 Sep 2022
- Ownership
- See footnote
- Footnotes
- F1, F4, F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
ARCH Venture Partners IX, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 7 footnotes
Footnote F1
Distribution of Common Stock held by a limited partnership to its partners for no consideration.
Footnote F2
These shares are directly held by ARCH Venture Fund IX, L.P. ("ARCH IX"). ARCH Venture Partners IX, L.P. ("GPLP"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC ("GPLLC"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the "ARCH Managing Directors"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any.
Footnote F3
These shares are directly held by ARCH Venture Fund IX Overage, L.P. ("ARCH Overage"). ARCH Venture Partners IX Overage, L.P. ("Overage GPLP"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any.
Footnote F4
Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person.
Footnote F5
Shares held directly by Crandell.
Footnote F6
Shares held directly by Bybee.
Footnote F7
Shares held by a trust for the benefit of family members of Bybee.